In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy

por Araújo, F., Shrestha, N., Gomes, M. J., Herranz-Blanco, B., Liu, D., Hirvonen, J. J., Granja, P. L., Santos, H. A., Sarmento, B.
Publicado 2016